Anandamide prior to sensitization increases cell-mediated immunity in mice

Alison Ribeiro1, Viviane Ferraz-de-Paula, Milena L Pinheiro

  • 1Neuroimmunomodulation Research Group, Department of Pathology, School of Veterinary Medicine, University of São Paulo, CEP 05508-270, São Paulo, SP Brazil.

Summary

Low-dose anandamide treatment before sensitization boosts the cell-mediated immunity (Th1 response) in mice. This immune enhancement involves increased dendritic cell activation and interferon-gamma production.

Related Concept Videos